Daijiworld Media Network - New York

New York, Feb 28: Human papillomavirus (HPV), often associated only with cervical cancer, affects everyone—men included. Experts warn that HPV is increasingly linked to cancers in men, particularly oropharyngeal (tonsil), anal, and penile cancers, yet awareness remains low.

Oropharyngeal cancer has been steadily rising over the past decade, with many patients lacking traditional risk factors like smoking or heavy alcohol use. Delayed diagnosis is common, as early symptoms—persistent throat pain, neck lumps, or swallowing difficulties—often seem minor.

Doctors emphasize that HPV spreads through intimate contact, and most people are exposed unknowingly. Men are also showing increasing rates of anal and penile cancers, which, though less frequent than throat cancer, can severely impact health and quality of life. Social stigma and a lack of public health education for men create barriers to timely diagnosis and preventive care.

Preventive action is key. The HPV vaccine offers strong protection against the virus strains most commonly linked to cancer, especially when administered before first exposure. Experts advocate for vaccination of both boys and girls, combined with public awareness campaigns highlighting early symptoms and risks for men.

Health authorities stress that HPV-related cancers are largely preventable and treatable with proper awareness and early intervention. Expanding education and vaccination programs to include men can significantly reduce the burden of HPV-linked cancers across society.